Quality by Design: The Future of Automated Pharmaceutical Labeling

Pharmaceutical labeling continues to change and adapt to trends in product presentation & regulations. Considering trends in automation, product handling, and robotics, it is important to have standardized approaches to pharmaceutical labeling platforms. Rising trends in single use autoinjector devices and personalized medicines require quality design with the future in mind. Pharmaceutical labeling machines need to ensure compatibility with future formats and this is critical to streamline production efforts. Automating labeling processes with robotics for small batches gives manufacturers greater efficiency and removes labor intensive loading and unloading, as well as possible quality errors from manual feeding and inspection. Learn how HERMA has standard labeling platforms for small to large batch pharmaceutical production, and everything in between.

Key Learning Objectives:
– Understand how Quality by Design (QbD) principles can be applied to pharmaceutical labeling to ensure scalability, compliance, and future format compatibility
– Learn how automation and robotics improve efficiency, reduce manual errors, and support small-batch and personalized medicine production
– Explore standardized labeling platform strategies that enable flexible deployment across varying batch sizes and product formats